IT1317001B1 - Uso della spirolaxina per il trattamento di patologie associate ad unaalterata angiogenesi. - Google Patents

Uso della spirolaxina per il trattamento di patologie associate ad unaalterata angiogenesi.

Info

Publication number
IT1317001B1
IT1317001B1 IT2000RM000129A ITRM20000129A IT1317001B1 IT 1317001 B1 IT1317001 B1 IT 1317001B1 IT 2000RM000129 A IT2000RM000129 A IT 2000RM000129A IT RM20000129 A ITRM20000129 A IT RM20000129A IT 1317001 B1 IT1317001 B1 IT 1317001B1
Authority
IT
Italy
Prior art keywords
spirolaxin
treatment
pathologies associated
altered angiogenesis
angiogenesis
Prior art date
Application number
IT2000RM000129A
Other languages
English (en)
Italian (it)
Inventor
Sergio Penco
Claudio Pisano
Giuseppe Giannini
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT2000RM000129A priority Critical patent/IT1317001B1/it
Publication of ITRM20000129A0 publication Critical patent/ITRM20000129A0/it
Priority to AU44533/01A priority patent/AU4453301A/en
Priority to PCT/IT2001/000113 priority patent/WO2001068070A2/fr
Publication of ITRM20000129A1 publication Critical patent/ITRM20000129A1/it
Application granted granted Critical
Publication of IT1317001B1 publication Critical patent/IT1317001B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT2000RM000129A 2000-03-13 2000-03-13 Uso della spirolaxina per il trattamento di patologie associate ad unaalterata angiogenesi. IT1317001B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2000RM000129A IT1317001B1 (it) 2000-03-13 2000-03-13 Uso della spirolaxina per il trattamento di patologie associate ad unaalterata angiogenesi.
AU44533/01A AU4453301A (en) 2000-03-13 2001-03-07 Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
PCT/IT2001/000113 WO2001068070A2 (fr) 2000-03-13 2001-03-07 Utilisation de spirolaxine dans le traitement de maladies associees a une angiogenese anormale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000129A IT1317001B1 (it) 2000-03-13 2000-03-13 Uso della spirolaxina per il trattamento di patologie associate ad unaalterata angiogenesi.

Publications (3)

Publication Number Publication Date
ITRM20000129A0 ITRM20000129A0 (it) 2000-03-13
ITRM20000129A1 ITRM20000129A1 (it) 2001-09-13
IT1317001B1 true IT1317001B1 (it) 2003-05-26

Family

ID=11454527

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000129A IT1317001B1 (it) 2000-03-13 2000-03-13 Uso della spirolaxina per il trattamento di patologie associate ad unaalterata angiogenesi.

Country Status (3)

Country Link
AU (1) AU4453301A (fr)
IT (1) IT1317001B1 (fr)
WO (1) WO2001068070A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010136A1 (it) * 2001-03-16 2002-09-16 Sigma Tau Ind Farmaceuti Composti utili per il trattamento di patologie che rispondono all'attivazione del recettore ppar-gamma.
ITMI20041279A1 (it) * 2004-06-24 2004-09-24 Pharmaproducts Uk Ltd Uso di calcio trifluoroacetato per la preparazione di medicamenti ad effetto anti-angiogenetico

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005204A1 (fr) * 1994-08-09 1996-02-22 Pfizer Inc. Derives de spirolaxine servant a traiter des maladies gastroduodenales
JPH107557A (ja) * 1996-06-17 1998-01-13 Banyu Pharmaceut Co Ltd 抗腫瘍性物質スピロラキシン
IL140729A0 (en) * 1998-07-14 2002-02-10 Bristol Myers Squibb Co Lysine binding fragments of angiostatin, pharmaceutical compositions containing the same and processes for the preparation thereof

Also Published As

Publication number Publication date
WO2001068070A8 (fr) 2001-11-08
ITRM20000129A0 (it) 2000-03-13
WO2001068070A3 (fr) 2002-04-18
ITRM20000129A1 (it) 2001-09-13
WO2001068070A2 (fr) 2001-09-20
AU4453301A (en) 2001-09-24

Similar Documents

Publication Publication Date Title
FI20001914A0 (fi) Elektrodirakenne
DE50112057D1 (de) Reinigungsfreundlicher Glaskeramikkörper
NL1017973A1 (nl) Inrichting.
NL1019181A1 (nl) Gestabiliseerd metalloceen-polypropeen.
BR0008833B1 (pt) Êmbolo construÍdo.
IT249776Y1 (it) Isolatore passante monolitico
IT1317001B1 (it) Uso della spirolaxina per il trattamento di patologie associate ad unaalterata angiogenesi.
IT1306193B1 (it) Uso degli ultrasuoni per il trattamento della sintomatologia dadecompressione.
ITTO20011197A0 (it) Corpo cilindrico ornamentale.
IT1317869B1 (it) Doccia.
ITAR990019V0 (it) Bugnatura imbutita con codulo.
ES1048246Y (es) Pieza ceramica.
IT246402Y1 (it) Il materasso del riposo.
FIU20000034U0 (fi) Kanteleen sävelvaihtomekanismi
IT1320746B1 (it) Saliscendi per lampadario.
ITPD20000054V0 (it) Struttura di sedia.
ITRM990326A0 (it) Nebulizzatore perfezionato.
IT1318461B1 (it) Tavolo allungabile.
ITGE990120A1 (it) Coppetta con salvietta.
ITRM20000040U1 (it) Easy playnet.
ES1049547Y (es) Estructura de soporte mejorada.
ITMI20001600A0 (it) Procedimento per la preparazione di 5-amino-4-alo-3-alchil isossazoli.
ES1050534Y (es) Inodoro con escobillero incorporado.
IT1311007B1 (it) Tavolo allungabile.
IT1311539B1 (it) Tavolo allungabile.